Logo image of TRMK

TRUSTMARK CORP (TRMK) Stock Fundamental Analysis

NASDAQ:TRMK - US8984021027 - Common Stock

40.49 USD
-0.14 (-0.34%)
Last: 8/28/2025, 12:51:01 PM
Fundamental Rating

4

Taking everything into account, TRMK scores 4 out of 10 in our fundamental rating. TRMK was compared to 393 industry peers in the Banks industry. While TRMK is still in line with the averages on profitability rating, there are concerns on its financial health. TRMK is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year TRMK was profitable.
TRMK had a positive operating cash flow in the past year.
TRMK had positive earnings in each of the past 5 years.
Each year in the past 5 years TRMK had a positive operating cash flow.
TRMK Yearly Net Income VS EBIT VS OCF VS FCFTRMK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

1.2 Ratios

With a decent Return On Assets value of 1.17%, TRMK is doing good in the industry, outperforming 77.10% of the companies in the same industry.
With a decent Return On Equity value of 10.48%, TRMK is doing good in the industry, outperforming 72.52% of the companies in the same industry.
Industry RankSector Rank
ROA 1.17%
ROE 10.48%
ROIC N/A
ROA(3y)0.84%
ROA(5y)0.86%
ROE(3y)8.71%
ROE(5y)8.76%
ROIC(3y)N/A
ROIC(5y)N/A
TRMK Yearly ROA, ROE, ROICTRMK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

TRMK's Profit Margin of 28.18% is fine compared to the rest of the industry. TRMK outperforms 75.06% of its industry peers.
TRMK's Profit Margin has improved in the last couple of years.
The Operating Margin and Gross Margin are not available for TRMK so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 28.18%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y20.81%
PM growth 5Y10.6%
GM growth 3YN/A
GM growth 5YN/A
TRMK Yearly Profit, Operating, Gross MarginsTRMK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

2

2. Health

2.1 Basic Checks

TRMK does not have a ROIC to compare to the WACC, probably because it is not profitable.
TRMK has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, TRMK has less shares outstanding
Compared to 1 year ago, TRMK has an improved debt to assets ratio.
TRMK Yearly Shares OutstandingTRMK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
TRMK Yearly Total Debt VS Total AssetsTRMK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

The Debt to FCF ratio of TRMK is 4.72, which is a neutral value as it means it would take TRMK, 4.72 years of fcf income to pay off all of its debts.
TRMK's Debt to FCF ratio of 4.72 is on the low side compared to the rest of the industry. TRMK is outperformed by 65.65% of its industry peers.
TRMK has a Debt/Equity ratio of 0.58. This is a neutral value indicating TRMK is somewhat dependend on debt financing.
The Debt to Equity ratio of TRMK (0.58) is worse than 78.63% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF 4.72
Altman-Z N/A
ROIC/WACCN/A
WACC16.05%
TRMK Yearly LT Debt VS Equity VS FCFTRMK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
TRMK Yearly Current Assets VS Current LiabilitesTRMK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 42.40% over the past year.
Measured over the past 5 years, TRMK shows a small growth in Earnings Per Share. The EPS has been growing by 5.95% on average per year.
TRMK shows a strong growth in Revenue. In the last year, the Revenue has grown by 42.40%.
TRMK shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.19% yearly.
EPS 1Y (TTM)42.4%
EPS 3Y9.95%
EPS 5Y5.95%
EPS Q2Q%37.31%
Revenue 1Y (TTM)42.4%
Revenue growth 3Y-4.97%
Revenue growth 5Y-2.19%
Sales Q2Q%42.74%

3.2 Future

The Earnings Per Share is expected to grow by 10.66% on average over the next years. This is quite good.
TRMK is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.64% yearly.
EPS Next Y19.6%
EPS Next 2Y10.66%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.76%
Revenue Next 2Y5.64%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
TRMK Yearly Revenue VS EstimatesTRMK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M
TRMK Yearly EPS VS EstimatesTRMK Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 11.37, the valuation of TRMK can be described as very reasonable.
TRMK's Price/Earnings ratio is a bit cheaper when compared to the industry. TRMK is cheaper than 68.96% of the companies in the same industry.
TRMK is valuated cheaply when we compare the Price/Earnings ratio to 27.14, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 10.63 indicates a reasonable valuation of TRMK.
TRMK's Price/Forward Earnings is on the same level as the industry average.
TRMK is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.80, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 11.37
Fwd PE 10.63
TRMK Price Earnings VS Forward Price EarningsTRMK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

TRMK's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. TRMK is cheaper than 71.76% of the companies in the same industry.
Industry RankSector Rank
P/FCF 9.6
EV/EBITDA N/A
TRMK Per share dataTRMK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.58
PEG (5Y)1.91
EPS Next 2Y10.66%
EPS Next 3YN/A

6

5. Dividend

5.1 Amount

TRMK has a Yearly Dividend Yield of 2.50%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 3.30, TRMK has a dividend in line with its industry peers.
TRMK's Dividend Yield is comparable with the S&P500 average which is at 2.34.
Industry RankSector Rank
Dividend Yield 2.5%

5.2 History

The dividend of TRMK has a limited annual growth rate of 0.23%.
TRMK has paid a dividend for at least 10 years, which is a reliable track record.
TRMK has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)0.23%
Div Incr Years0
Div Non Decr Years34
TRMK Yearly Dividends per shareTRMK Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

26.59% of the earnings are spent on dividend by TRMK. This is a low number and sustainable payout ratio.
The dividend of TRMK is growing, but earnings are growing more, so the dividend growth is sustainable.
DP26.59%
EPS Next 2Y10.66%
EPS Next 3YN/A
TRMK Yearly Income VS Free CF VS DividendTRMK Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
TRMK Dividend Payout.TRMK Dividend Payout, showing the Payout Ratio.TRMK Dividend Payout.PayoutRetained Earnings

TRUSTMARK CORP

NASDAQ:TRMK (8/28/2025, 12:51:01 PM)

40.49

-0.14 (-0.34%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)07-22 2025-07-22/amc
Earnings (Next)10-20 2025-10-20/amc
Inst Owners75.03%
Inst Owner Change-1.84%
Ins Owners1.71%
Ins Owner Change-0.28%
Market Cap2.44B
Analysts76.67
Price Target44.47 (9.83%)
Short Float %2.84%
Short Ratio4.98
Dividend
Industry RankSector Rank
Dividend Yield 2.5%
Yearly Dividend0.93
Dividend Growth(5Y)0.23%
DP26.59%
Div Incr Years0
Div Non Decr Years34
Ex-Date08-29 2025-08-29 (0.24)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.65%
Min EPS beat(2)3.87%
Max EPS beat(2)5.43%
EPS beat(4)4
Avg EPS beat(4)4.78%
Min EPS beat(4)0.64%
Max EPS beat(4)9.2%
EPS beat(8)7
Avg EPS beat(8)2.17%
EPS beat(12)10
Avg EPS beat(12)-10.81%
EPS beat(16)12
Avg EPS beat(16)-8.84%
Revenue beat(2)0
Avg Revenue beat(2)-0.91%
Min Revenue beat(2)-0.95%
Max Revenue beat(2)-0.88%
Revenue beat(4)1
Avg Revenue beat(4)-0.28%
Min Revenue beat(4)-0.95%
Max Revenue beat(4)1.08%
Revenue beat(8)1
Avg Revenue beat(8)-4.59%
Revenue beat(12)3
Avg Revenue beat(12)-2.93%
Revenue beat(16)4
Avg Revenue beat(16)-2.69%
PT rev (1m)4.06%
PT rev (3m)5.19%
EPS NQ rev (1m)6.99%
EPS NQ rev (3m)8.66%
EPS NY rev (1m)4.59%
EPS NY rev (3m)4.89%
Revenue NQ rev (1m)1.39%
Revenue NQ rev (3m)1.74%
Revenue NY rev (1m)0.95%
Revenue NY rev (3m)1.05%
Valuation
Industry RankSector Rank
PE 11.37
Fwd PE 10.63
P/S 3.17
P/FCF 9.6
P/OCF 8.77
P/B 1.18
P/tB 1.52
EV/EBITDA N/A
EPS(TTM)3.56
EY8.79%
EPS(NY)3.81
Fwd EY9.41%
FCF(TTM)4.22
FCFY10.42%
OCF(TTM)4.62
OCFY11.41%
SpS12.76
BVpS34.3
TBVpS26.56
PEG (NY)0.58
PEG (5Y)1.91
Profitability
Industry RankSector Rank
ROA 1.17%
ROE 10.48%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 28.18%
GM N/A
FCFM 33.05%
ROA(3y)0.84%
ROA(5y)0.86%
ROE(3y)8.71%
ROE(5y)8.76%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y20.81%
PM growth 5Y10.6%
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF 4.72
Debt/EBITDA N/A
Cap/Depr 63.77%
Cap/Sales 3.13%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 117.28%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score7
WACC16.05%
ROIC/WACCN/A
Cap/Depr(3y)98.8%
Cap/Depr(5y)87.82%
Cap/Sales(3y)5.7%
Cap/Sales(5y)5.28%
Profit Quality(3y)164.76%
Profit Quality(5y)146.26%
High Growth Momentum
Growth
EPS 1Y (TTM)42.4%
EPS 3Y9.95%
EPS 5Y5.95%
EPS Q2Q%37.31%
EPS Next Y19.6%
EPS Next 2Y10.66%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)42.4%
Revenue growth 3Y-4.97%
Revenue growth 5Y-2.19%
Sales Q2Q%42.74%
Revenue Next Year6.76%
Revenue Next 2Y5.64%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y103.55%
FCF growth 3Y-34.72%
FCF growth 5Y0.61%
OCF growth 1Y61.99%
OCF growth 3Y-30.53%
OCF growth 5Y0.09%